Debt investors
Explore Novonesis' EMTN programme and related information.
EMTN programme 2026
On March 10 2026, Novonesis established a Euro Medium Term Note programme (the “Programme”) listed on the Luxembourg Stock Exchange.
You can download the related documents here:
- Base Prospectus
- Agency Agreement
- Deed of Covenant
- Final Terms 2026-2030
- Final Terms 2026-2033
- Final Terms 2026-2037
- Credit Rating
- Articles of Association
- Annual Report
Issuer: Novozymes A/S
Programme size: EUR 4,000,000,000
Arranger: BNP Paribas
Dealers: BNP Paribas, BofA Securities, Citi, Danske Bank, HSBC, Nordea, Nykredit and SEB
Outstanding bonds
| Issuer | Amount (millions) | Currency | Coupon | Issue date: | Maturity date | ISIN |
|---|---|---|---|---|---|---|
| Novozymes A/S | 500 | EUR | 3.25% | March 19, 2026 | March 19, 2030 | XS3320129599 |
| Novozymes A/S | 600 | EUR | 3.63% | March 19, 2026 | March 19, 2033 | XS3320130175 |
| Novozymes A/S | 600 | EUR | 4.00% | March 19, 2026 | March 19, 2037 | XS3320130258 |
Credit ratings
| Rating agency | Corporate rating | Outlook | Download |
|---|---|---|---|
| S&P Global Ratings | A- | Stable |
Contact investor relations
Should you have any questions about results and events, please don't hesitate to get in touch with our investor relations team.